---
title: "Transtek plans to grant 2 million stock options with an exercise price of RMB 15.21 per share"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256812581.md"
description: "According to the Zhitong Finance APP, Transtek disclosed its 2025 stock option incentive plan (draft), which proposes to grant a total of 2 million stock options to 40 incentive recipients, with an exercise price of RMB 15.21 per option. The validity period of this incentive plan is from the date of stock option authorization until all stock options granted to the incentive recipients are exercised or canceled, lasting no more than 36 months"
datetime: "2025-09-10T22:36:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256812581.md)
  - [en](https://longbridge.com/en/news/256812581.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256812581.md)
generator: "portal-rs"
---

# Transtek plans to grant 2 million stock options with an exercise price of RMB 15.21 per share

According to the Zhitong Finance APP, Transtek (300562.SZ) has disclosed the draft of its 2025 stock option incentive plan, proposing to grant a total of 2 million stock options to 40 incentive recipients, with an exercise price of 15.21 yuan per share. The validity period of this incentive plan is from the date of stock option authorization until all granted stock options are exercised or canceled, lasting no more than 36 months

### Related Stocks

- [300562.CN](https://longbridge.com/en/quote/300562.CN.md)

## Related News & Research

- [Jiangsu Yuyue Medical Equipment & Supply: Net profit fell 29.92% year-over-year, but overseas and CGM sales grew sharply](https://longbridge.com/en/news/296602713.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [Asker Healthcare Group buys Baltic medtech distributor Ambercell Solutions](https://longbridge.com/en/news/296306272.md)
- [Nexstim receives NBS 6 system order from European hospital customer](https://longbridge.com/en/news/296574081.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**